Already early studies reported high levels of proinflammatory cytokines, such as IL-1β, TNF-α, GM-CSF, in JMML patients plasma (Bagby et al., 1988; Freedman et al., 1992). This evidence concerns the gene IL1B and juvenile myelomonocytic leukemia.